Correlation of ERCC1 expression in peripheral blood lymphocytes with outcomes of patients with gastric cancer treated with oxaliplatin-based adjuvant chemotherapy. [electronic resource]
Producer: 20160915Description: 15921-9 p. digitalISSN:- 1676-5680
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Chemotherapy, Adjuvant
- DNA-Binding Proteins -- genetics
- Endonucleases -- genetics
- Female
- Follow-Up Studies
- Gene Expression
- Humans
- Immunohistochemistry
- Kaplan-Meier Estimate
- Lymphocytes -- metabolism
- Male
- Middle Aged
- Neoplasm Metastasis
- Neoplasm Staging
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Prognosis
- Stomach Neoplasms -- drug therapy
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.